Khảo sát in silico, xây dựng cơ sở khoa học cho việc phát hiện kết hợp yếu tố nhiễm và bất ổn di truyền trong ung thư vòm họng

Chang HW., Chan ., Kwong L., Wei WI., Sham JS., Yuen P. (2003). “Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swa and peripheral lood of nasopharyngeal carcinoma patient”. Int J Cancer 105, p.851– 855.

Chim CS., Liang R., Fung TK., Choi CL., Kwong YL. (2007). “Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma”. J Clin Pathol, 60 p.664-669.

Eugene AC., Julie MW., David ET., Stacey LI. (200 ). “ asopharyngeal Carcinoma: The Role of the Epstein-Barr Virus”. Medscape J Med., 10(7), p.165.

Kong WJ., Zhang S., Guo CK., Wang YJ., Chen X., Zhang SL., Zhang D., Liu Z., Kong W. (2006). “Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma”. Anticancer Drugs 17(3), p.251-259.

Kwong J., Lo KW., To KF., Teo PM., Johnson PJ., Huang P. (2002).”‘Promoter

Hypermethylation of Multiple Genes in asopharyngeal Carcinoma’. Clin Cancer Res, 8, p.131-137.

Leah CP., Marcie JG., Leah AD., Daniel EJ., Kieu D., Carmen ST., Steven AB. (2009). “ Dual promoter regulation of death-associated protein kinase gene leads to differentially silenced transcripts by methylation in cancer”. Carcinogenesis, 30(12), p. 2023–2030.

Leight ER., Sugden B. (2000). “EB -1: a protein pivotal to latent infection by EpsteinBarr virus’. Rev Med Virol, 10, p.83-100.

Liu JB., Qiang FL., ong J., Cai J., Zhou SH., Shi MX. (2011) ‘Plasma methylation of Wnt antagonists predicts recurrence of esophageal squamous cell carcinoma’. World J Gastroenterol., 17(44), p.4917-4921.

Manel E. (2005). “ DNA methylation, epigenetics and metastasis”. Springer, ISBN-10 1-4020-3641-8.

Matthew PT., Razelle K. (2004). “Epstein-Barr Virus and Cancer”. Clin Cancer Res, 10, p.803-821.

Misener S., Krawetz S . (1999). “Methods in Molecular Biology’. © Humana Press, 132, p.365-386.

Niklinska W., Naumnik W., Sulewska A., Kozlowski M., Pankiewicz., Milewski R. (2009). “Prognostic significance of PK and R SSF1 promoter hypermethylation in Non-Small Cell Lung Cancer ( SCLC)”. Folia histochem cytobiol., 47, p.275-280.

Saeid G., Ali MA. (2012). “Non-Invasive Detection of Esophageal Cancer using Genetic Changes in Circulating Cell-Free DNA ”. Avicenna J Med Biotechnol., 4(1), p.3-13.

Sivachandran N., Wang X., Frappier L. (2012). “Functions of the Epstein-Barr virus EB 1 protein in viral reactivation and lytic infection”. J Virol., 86(11), p.6146-6158.

Susanna HH., Sagung RI., Luh PLI., Ahma H., Sylvia D., Sofia MH., Renske DMS., strid EG., Jaap MM. (2011). “Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population”. Molecular Cancer, 10, p.48.

Wong TS, Chang HW, Tang KC, Wei WI, Kwong DL, Sham JS, Yuen AP, Kwong YL. (2002). “High frequency of promoter hypermethylation of the death-associated proteinkinase gene in nasopharyngeal carcinoma and its detection in the peripheral blood of patients”. Clin Cancer Res., 8(2), p.433-437.

World Health Oragnization (2012). “Estimated cancer incidence, Mortality and prevalence worldwide in 2012”. International agency for research on cancer.

Wu LM., Zhang F., Zhou L., Yang Z., Xie HY., Zheng SS. (2010). “Predictive value of CpG island methylator phenotype for tumor recurrence in hepatitis B virus-associated hepatocellular carcinoma following liver transplantation”. BMC Cancer, 10, p.1471-2407.

Young LS., Dawson CW., Clark D., Rupani H., Busson P., Tursz T., Johnson A.,

Rickinson AB. (19 ). “Epstein-Barr virus gene expression in nasopharyngeal carcinoma”. J Gen Virol., 69(5), p.1051-1065.

Zhang Z., Sun D., Hutajulu SH., Nawaz I., Nguyen Van D., Huang G., Haryana SM., Middeldorp JM., Ernberg I., Hu LF. (2012). “ evelopment of a on-Invasive Method, Multiplex Methylation Specific PCR (MMSP), for Early Diagnosis of Nasopharyngeal Carcinoma”. PLoS ONE, 7(11), p.1-6.

Xem thêm